Almirall announces Danish launch of MC2 Therapeutics-developed psoriasis cream
Almirall is launching psoriasis cream Wynzora in Denmark. The treatment has been inlicensed from Danish firm MC2 Therapeutics, where the CEO says ”it is a special feeling” to see Wynzora launched in its home country.
by christopher due karlsson, translated by daniel pedersen
Spanish dermatology firm Almirall is launching Wynzora, a plaque psoriasis cream developed by Danish firm MC2 Therapeutics, in Denmark, the firm has announced in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
